Biotech News

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026

SIGA Technologies Inc (SIGA)SIGA Technologies IncEarnings

SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2026.

Related news

SIGA Technologies Inc

SIGA Technologies is a specialty pharmaceutical company best known for its antiviral countermeasure portfolio, especially against orthopox and smallpox-related threats. Its story is tied to government procurement and biodefense demand.

Recent company news

Stock data

Close
2.65 USD
Market cap
309.85M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States